Cancer Research

Philly gene therapy companies tap into city’s workforce training program for lab techs

Penn Medicine is noted for spearheading gene therapy for cancer treatment, being the first in the nation to use a gene editing tool to combat cancer in 2019.

Microscopic view of a DNA chain disintegrating.

QR code for cancer cells

Researchers from Penn Engineering have created a new synthetic biology approach to uncover why some cells become resistant to anti-cancer therapies.

Blackstone president’s foundation awards $15 million to cancer researchers in Greater Boston

Jon and Mindy Gray are noted for their cancer-related donations to the Perelman School of Medicine’s Basser Center, which they established in 2012.

Cancer patients with bowel obstructions may benefit from surgery

Robert Krouse of the Perelman School of Medicine comments on research that suggests surgery should be offered sooner rather than later to patients with advanced abdominal tumors.

Antibody treatment prevents graft versus host disease in advanced preclinical tests

Penn Medicine, Dana-Farber Cancer Institute, and Boston Children’s Hospital research finds single antibody treatment blocked donor T-cell attack and increased survival rates in preclinical models.

Microscopic view of bone marrow slide showing multiple myeloma, a type of bone marrow cancer.

RNA nanoparticle therapy stops the spread of incurable bone marrow cancer

By creating a roadblock in cancer’s commute through the body, researchers removed a longstanding barrier in the treatment of multiple myeloma.

A cancer patient holding hands with a relative in consult with a doctor in a hospital bed.

Data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

A new Penn Medicine study finds indefinite immunotherapy is not associated with improved survival in large, retrospective cohort.

Why new cancer treatment discoveries are proliferating

The approval of CAR T cell therapy ushered in a new era for cancer treatment.

The path from innovation to implementation

Penn’s infrastructure in both supporting clinical research and forging commercial partnerships smooths the way from idea to approval.

A man sits with a doctor holding an iPad.

Three things to know about BRCA mutations in men

Kara Maxwell, director of the Men & BRCA Program at the Basser Center, is bridging the knowledge gap about how BRCA mutations affect men.

Filters